Genotoxicity evaluation of self-assembled-micelle inhibitory RNA-targeting amphiregulin (SAMiRNA-AREG), a novel siRNA nanoparticle for the treatment of fibrotic disease

References

• Akyil, D., et al., 2012. Genotoxic and mutagenic effects of aqueous extract from aerial parts of Achillea teretifolia. Turkish Journal of Biology, 36, 441–448.
   Web of Science ®Google Scholar
• Arriaga-Alba, M., et al., 2013. Antimutagenic evaluation of vitamins B1, B6 and B12 in vitro and in vivo, with the Ames test. Food and Chemical Toxicology, 53, 228–234.
   PubMed Web of Science ®Google Scholar
• Ashby, J., 1985. Is there a continuing role for the intraperitoneal injection route of exposure in short-term redolent genotoxicity assays? Mutation Research/Genetic Toxicology, 156 (3), 239–243.
   PubMedGoogle Scholar
• Berman, C.L., et al., 2016. OSWG Recommendations for genotoxicity testing of novel oligonucleotide-based therapeutics. Nucleic Acid Therapeutics, 26 (2), 73–85.
   PubMed Web of Science ®Google Scholar
• Bolognesi, C. and Hayashi, M., 2011. Micronucleus assay in aquatic animals. Mutagenesis, 26 (1), 205–213.
   PubMed Web of Science ®Google Scholar
• Bonassi, S., et al., 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28 (3), 625–631.
   PubMed Web of Science ®Google Scholar
• Bonnans, C., et al., 2014. Remodelling the extracellular matrix in development and disease. Nature Reviews. Molecular Cell Biology, 15 (12), 786–801.
   PubMed Web of Science ®Google Scholar
• Bumcrot, D., et al., 2006. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chemical Biology, 2 (12), 711–719.
   PubMed Web of Science ®Google Scholar
• Cortés, F., et al., 2004. Toward a comprehensive model for induced endoreduplication. Life Sciences, 76 (2), 121–135.
   PubMed Web of Science ®Google Scholar
• DiFiglia, M., et al., 2007. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proceedings of the National Academy of Sciences of the United States of America, 104 (43), 17204–17209.
   PubMed Web of Science ®Google Scholar
• Emerit, L., 2007. Clastogenic factors as potential biomarkers of increased superoxide production. Biomarker Insights, 2, 429–438.
   PubMedGoogle Scholar
• Escobar, P.A., et al., 2013. Bacterial mutagenicity screening in the pharmaceutical industry. Mutation Research, 752 (2), 99–118.
   PubMed Web of Science ®Google Scholar
• Falsini, S., et al., 2014. Time resolved SAXS to study the complexation of siRNA with cationic micelles of divalent surfactants. Soft Matter, 10 (13), 2226–2233.
   PubMed Web of Science ®Google Scholar
• Gollapudi, B. and Kamra, O.P., 1979. Application of a simple Giemsa staining method in the micronucleus test. Mutation Research, 64 (1), 45–46.
   PubMed Web of Science ®Google Scholar
• Gharaee-Kermani, M., et al., 2007. Current and emerging drugs for idiopathic pulmonary fibrosis. Expert Opinion on Emerging Drugs, 12 (4), 627–646.
   PubMed Web of Science ®Google Scholar
• Henry, S.P., et al., 2002. Assessment of the genotoxic potential of ISIS 2302: a phosphorothioate oligodeoxynucleotide. Mutagenesis, 17 (3), 201–209.
   PubMed Web of Science ®Google Scholar
• Janas, M.M., et al., 2016. Exposure to siRNA-GalNAc conjugates in systems of the standard test battery for genotoxicity. Nucleic Acid Therapeutics, 26 (6), 363–371.
   PubMed Web of Science ®Google Scholar
• Janas, M.M., et al., 2018. The nonclinical safety profile of GalNAc-conjugated RNAi therapeutics in subacute studies. Toxicologic Pathology, 46 (7), 735–745.
   PubMed Web of Science ®Google Scholar
• JEMS-MMS, 1988. Atlas of chromosome aberration by chemicals. Tokyo, Japan: Japanese Environmental Mutagen Society-Mammalian Mutagenicity Study Group.
   Google Scholar
• Jeong, J.H., et al., 2009. siRNA conjugate delivery systems. Bioconjugate Chemistry, 20 (1), 5–14.
   PubMed Web of Science ®Google Scholar
• Jeong, M.H., et al., 2018. In vitro and in vivo evaluation of the genotoxicity of Eriobotrya japonica leaf extract. Regulatory Toxicology and Pharmacology : RTP, 99, 238–243.
   PubMed Web of Science ®Google Scholar
• Kanasty, R., et al., 2013. Delivery materials for siRNA therapeutics. Nature Materials, 12 (11), 967–977.
   PubMed Web of Science ®Google Scholar
• Kim, H.Y., et al., 2018a. Genotoxicity study of glycopeptide (G-7%NANA). Toxicological Research, 34 (3), 259–266.
   PubMed Web of Science ®Google Scholar
• Kim, H.Y., et al., 2018b. Protective effects of Nintedanib against polyhexamethylene guanidine phosphate-induced lung fibrosis in mice. Molecules, 23 (8), 1974.
   PubMed Web of Science ®Google Scholar
• Konuk, M., et al., 2008. A study on mutagenicity of different types of pesticides by using of Ames/Salmonella/microsome test system. Fresenius Environmental Bulletin, 17 (4), 463–466.
   Web of Science ®Google Scholar
• Lee, C.M., et al., 2014. Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis. The Korean Journal of Internal Medicine, 29 (3), 281–290.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2016. Succinate/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis. Frontiers in Immunology, 7, 532.
   PubMed Web of Science ®Google Scholar
• Luo, H., et al., 2016. Amygdalin inhibits HSC-T6 cell proliferation and fibrosis through the regulation of TGF-β/CTGF. Mollecular & Cellular Toxicology, 12, 256–271.
   Web of Science ®Google Scholar
• Mauviel, A., 2005. Transforming growth factor-beta: a key mediator of fibrosis. Methods in Molecular Medicine, 117, 69–80.
   PubMedGoogle Scholar
• Minton, K., 2014. Extracellular matrix: Preconditioning the ECM for fibrosis. Nature Reviews. Molecular Cell Biology, 15 (12), 766–767.
   PubMedGoogle Scholar
• Mortelmans, K. and Zeiger, E., 2000. The Ames/Salmonella/microsome mutagenicity assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 455 (1-2), 29–60.
   PubMed Web of Science ®Google Scholar
• Murgia, E., et al., 2008. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 639 (1-2), 27–34.
   PubMed Web of Science ®Google Scholar
• OECD, 1997. OECD Guideline for Testing of Chemicals: TG 471: Bacterial Reverse Mutation Test.
   Google Scholar
• OECD, 2014a. OECD Guideline for Testing of Chemicals. TG 473: In vitro Mammalian Chromosome Aberration Test.
   Google Scholar
• OECD, 2014b. OECD Guideline for Testing of Chemicals. TG 474: Mammalian Erythrocyte Micronucleus Test.
   Google Scholar
• Robbins, M., et al., 2009. siRNA and innate immunity. Oligonucleotides, 19 (2), 89–102.
   PubMed Web of Science ®Google Scholar
• Savage, J.R.K., 1991. Chromosomal aberrations: basic and applied aspects. Genetical Research, 57 (2), 201–203.
   Google Scholar
• Schmid, W., 1975. The micronucleus test. Mutation Research/Environmental Mutagenesis and Related Subjects, 31 (1), 9–15.
   PubMed Web of Science ®Google Scholar
• Steinbach, J.M., et al., 2012. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. Journal of Controlled Release : official Journal of the Controlled Release Society, 162 (1), 102–110.
   PubMed Web of Science ®Google Scholar
• Thannickal, V.J., et al., 2005. Emerging drugs for idiopathic pulmonary fibrosis. Expert Opinion on Emerging Drugs, 10 (4), 707–727.
   PubMedGoogle Scholar
• Tseng, Y.C., et al., 2009. Lipid-based systemic delivery of siRNA. Advanced Drug Delivery Reviews, 61 (9), 721–731.
   PubMed Web of Science ®Google Scholar
• Wynn, T.A., 2008. Cellular and molecular mechanisms of fibrosis. The Journal of Pathology, 214 (2), 199–210.
   PubMed Web of Science ®Google Scholar
• Yoon, P.O., et al., 2016. Self-assembled micelle interfering RNA for effective and safe targeting of dysregulated genes in pulmonary fibrosis. The Journal of Biological Chemistry, 291 (12), 6433–6446.
   PubMed Web of Science ®Google Scholar
• Yun, J.W., et al., 2017. Evaluation of in vitro and in vivo genotoxicity of Angelica acutiloba in a standard battery of assays. Laboratory Animal Research, 33 (3), 231–236.
   PubMedGoogle Scholar
• Zhou, Y., et al., 2012. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis. The Journal of Biological Chemistry, 287 (50), 41991–42000.
   PubMed Web of Science ®Google Scholar